Terms: = Lung cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Prognosis
56 results:
1. Direct interaction of platelet with tumor cell aggravates hepatocellular carcinoma metastasis by activating TLR4/ADAM10/CX3CL1 axis.
Gao JH; He AD; Liu LM; Zhou YJ; Guo YW; Lu M; Zeng XB; Gong X; Lu YJ; Liang HF; Zhang BX; Ma R; Zhang RY; Ming ZY
Cancer Lett; 2024 Mar; 585():216674. PubMed ID: 38280480
[TBL] [Abstract] [Full Text] [Related]
2. Relationship between the expression of ARHGAP25 and rhoa in non-small cell lung cancer and vasculogenic mimicry.
Shi F; Wu J; Jia Q; Li K; Li W; Shi Y; Wang Y; Wu S
BMC Pulm Med; 2022 Oct; 22(1):377. PubMed ID: 36207695
[TBL] [Abstract] [Full Text] [Related]
3. ARHGEF40 promotes non-small cell lung cancer proliferation and invasion via the AKT-Wnt axis by binding to rhoa.
Gu J; Zhang X; Jiang G; Li Q; Wang E; Yu J
Mol Carcinog; 2022 Nov; 61(11):1016-1030. PubMed ID: 36000254
[TBL] [Abstract] [Full Text] [Related]
4. LINC00891 regulated by miR-128-3p/GATA2 axis impedes lung cancer cell proliferation, invasion and EMT by inhibiting rhoa pathway.
Zhang Y; Song D; Peng Z; Wang R; Li K; Ren H; Sun X; Du N; Tang SC
Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):378-387. PubMed ID: 35538035
[TBL] [Abstract] [Full Text] [Related]
5. Nogo-B promotes invasion and metastasis of nasopharyngeal carcinoma via rhoa-SRF-MRTFA pathway.
Wang J; Zhong Q; Zhang H; Liu S; Li S; Xia T; Xiao Z; Chen R; Ye Y; Liang F; Han P; Huang X
Cell Death Dis; 2022 Jan; 13(1):76. PubMed ID: 35075114
[TBL] [Abstract] [Full Text] [Related]
6. Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial.
Katz SI; Roshkovan L; Berger I; Friedberg JS; Alley EW; Simone CB; Haas AR; Cengel KA; Sterman DH; Albelda SM
Lung Cancer; 2021 Apr; 154():5-12. PubMed ID: 33561782
[TBL] [Abstract] [Full Text] [Related]
7. PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway.
Hu Y; Cheng Y; Jiang X; Zhang Y; Wang H; Ren H; Xu Y; Jiang J; Wang Q; Su H; Zhang B; Qiu X
Exp Cell Res; 2021 Mar; 400(2):112496. PubMed ID: 33485844
[TBL] [Abstract] [Full Text] [Related]
8. miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/rhoa pathway.
Duan J; Wang L; Shang L; Yang S; Wu H; Huang Y; Miao Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33269380
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
[TBL] [Abstract] [Full Text] [Related]
10. External validation of life expectancy prognostic models in patients evaluated for palliative radiotherapy at the end-of-life.
Mojica-Márquez AE; Rodríguez-López JL; Patel AK; Ling DC; Rajagopalan MS; Beriwal S
Cancer Med; 2020 Aug; 9(16):5781-5787. PubMed ID: 32592315
[TBL] [Abstract] [Full Text] [Related]
11. LncNORAD interference inhibits tumor growth and lung cancer cell proliferation, invasion and migration by down-regulating CXCR4 to suppress rhoa/ROCK signaling pathway.
Wu Y; Shen QW; Niu YX; Chen XY; Liu HW; Shen XY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5446-5455. PubMed ID: 32495879
[TBL] [Abstract] [Full Text] [Related]
12. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
Liao D; Zhong L; Yin J; Zeng C; Wang X; Huang X; Chen J; Zhang H; Zhang R; Guan XY; Shuai X; Sui J; Gao S; Deng W; Zeng YX; Shen JN; Chen J; Kang T
Nat Cell Biol; 2020 Jul; 22(7):868-881. PubMed ID: 32483387
[TBL] [Abstract] [Full Text] [Related]
13. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of rhoa.
Liu Q; Huang X; Li Q; He L; Li S; Chen X; Ouyang Y; Wang X; Lin C
FASEB J; 2020 Aug; 34(8):9959-9971. PubMed ID: 32427399
[TBL] [Abstract] [Full Text] [Related]
14. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis.
Ito M; Miyata Y; Tsutani Y; Ito H; Nakayama H; Imai K; Ikeda N; Okada M
Lung Cancer; 2020 Mar; 141():107-113. PubMed ID: 32035371
[TBL] [Abstract] [Full Text] [Related]
15. GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway.
Wang Q; Ren H; Xu Y; Jiang J; Wudu M; Liu Z; Su H; Jiang X; Zhang Y; Zhang B; Qiu X
Exp Cell Res; 2020 Feb; 387(2):111806. PubMed ID: 31891681
[TBL] [Abstract] [Full Text] [Related]
16. [Correlation between Lymph Node Ratio and Clinicopathological Features and prognosis of IIIa-N2 Non-small Cell lung cancer].
Zhang S; Wang L; Lu F; Pei Y; Yang Y
Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):702-708. PubMed ID: 31771739
[TBL] [Abstract] [Full Text] [Related]
17. Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma.
Zhou J; Zhang S; Xu Y; Ye W; Li Z; Chen Z; He Z
Clin Exp Metastasis; 2020 Feb; 37(1):115-124. PubMed ID: 31463796
[TBL] [Abstract] [Full Text] [Related]
18. Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study.
Yang JR; Xu JY; Chen GC; Yu N; Yang J; Zeng DX; Gu MJ; Li DP; Zhang YS; Qin LQ
Sci Rep; 2019 May; 9(1):8143. PubMed ID: 31148582
[TBL] [Abstract] [Full Text] [Related]
19. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
[TBL] [Abstract] [Full Text] [Related]
20. Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis.
Yang L; Wang S; Gerber DE; Zhou Y; Xu F; Liu J; Liang H; Xiao G; Zhou Q; Gazdar A; Xie Y
Lung Cancer; 2018 Jun; 120():22-26. PubMed ID: 29748011
[TBL] [Abstract] [Full Text] [Related]
[Next]
